Derivation and Validation of Hemodynamic Phenotypes of Cardiac Surgery

NCT ID: NCT07085208

Last Updated: 2025-07-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

10847 participants

Study Classification

OBSERVATIONAL

Study Start Date

2016-04-01

Study Completion Date

2024-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Background \& Objective:

Cardiac surgery patients differ significantly in their health conditions and how they react during operations. Standard risk assessments before surgery often miss the real-time changes happening inside a patient's body during the procedure, which can affect their recovery. Therefore, researchers conducted this study to find different groups (phenotypes) of patients who face varying risks for poor outcomes. They did this by using advanced computer learning techniques to analyze a lot of detailed health information collected both before and during surgery.

Methods:

This was a study that looked back at patient records from several hospitals. Researchers gathered a large amount of patient information from before surgery, including their basic health details and lab results. They also collected very detailed measurements of patients' vital signs taken during surgery, noting how these changed over time. Then, a computer program that can find patterns without being told what to look for (unsupervised hierarchical clustering) was used to sort patients into distinct groups based on this combined data.

Clinical Relevance:

This study expects to show that using data to identify patient groups can reveal differences that traditional methods miss. These new patient groups, which are based on how their blood flow and vital signs behave, offer a new way to understand risks in real-time. This could help doctors to predict problems more accurately and create personalized care plans for each patient around the time of surgery, which has great potential for practical use in hospitals.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Phenotyping Machine Learning Cardiac Surgery Hemodynamic Parameters

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Unsupervised Machine Learning for Clinical Phenotyping

This is a data-driven study that uses an unsupervised machine learning algorithm to perform clustering on patient multimodal features. These features include: preoperative demographics, comorbidities, and laboratory data; surgical information; and high-resolution intraoperative data, most notably continuous vital sign trajectories.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients aged 18 years or older
* Patients who underwent cardiac surgery with cardiopulmonary bypass

Exclusion Criteria

* Incomplete information on surgical procedures,
* With History of prior cardiac surgery or underwent second surgery during the same hospitalization
* Insufficient valid perioperative vital sign monitoring data
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Nanjing First Hospital, Nanjing Medical University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

KY20250224-KS-04

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.